Hemoglobin extravasation in the brain of rats exchange-transfused with hemoglobin-based oxygen carriers
Source abstract
Abstract
Haemoglobin (Hb)-based oxygen carriers are under consideration as oxygen therapeutics. Their effect on apoptosis is critical, because the onset of pro-apoptotic pathways may lead to tissue damage. MP4OX, a polyethylene glycol-conjugated human Hb preserves the baseline level of neuron apoptosis with respect to sham. Here we develop a method for measuring Hb extravasation in brain. We exchange transfused rats by haemorrhaging 50% of their blood with simultaneous, isovolemic replacement with Hextend (negative control), MP4OX, or αα-cross-linked Hb. Animals were sacrificed 2 h after transfusion, brain tissue was harvested and processed for double-staining immunofluorescence, whereby Hb ? chain and NeuN (a neuron protein) were stained and quantitated. Whereas Hextend did not induce Hb extravasation, in both MP4OX and ??Hb brains Hb molecules were detected outside neurons. The level of extravasated Hb chains was > 3-fold higher in Hb compared to MP4OX. Western blot analysis revealed that the expression levels of protein related to redox imbalance (e.g., Nrf2, iNOS and ERK phosphorylation) were higher in ααHb than MP4OX. In conclusions, higher Hb extravasation in ααHb than MP4OX induces redox imbalance, which causes higher anti-oxidant response. Whereas Nrf2 response may be considered protective, iNOS response appears damaging.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Hemoglobin structure and function · Heme Oxygenase-1 and Carbon Monoxide · Neuroscience of respiration and sleep
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Health Science, University of Milan, Milan, Italy;
NovoSang, Inc., San Diego, CA, USA;
Sangart Inc., San Diego, CA, USA
Funding
Università degli Studi di Milano · U.S. Army Medical Department
References (37)
Show source-provided references
1. 10.1152/ajpheart.1999.277.2.H65010.1152/ajpheart.1999.277.2.H650 ↗
2. 10.1089/ars.2004.6.101910.1089/ars.2004.6.1019 ↗
3. 10.1016/B978-012759760-7/50052-410.1016/B978-012759760-7/50052-4 ↗
4. 10.1016/j.ajpath.2010.12.00610.1016/j.ajpath.2010.12.006 ↗
5. 10.1016/j.mvr.2008.07.00210.1016/j.mvr.2008.07.002 ↗
6. 10.1113/jphysiol.2008.15472410.1113/jphysiol.2008.154724 ↗
7. 10.1213/ANE.0b013e31820ad60710.1213/ANE.0b013e31820ad607 ↗
8. Keipert PE · J Lab Clin Med · 1994 · 123 · 701
9. 10.1158/0008-5472.CAN-10-300710.1158/0008-5472.CAN-10-3007 ↗
10. 10.1073/pnas.91.17.813710.1073/pnas.91.17.8137 ↗
11. 10.1002/j.1460-2075.1992.tb05088.x10.1002/j.1460-2075.1992.tb05088.x ↗
12. Misra HP · J Biol Chem · 1972 · 247 · 696010.1016/S0021-9258(19)44679-6 ↗
13. 10.3389/fonc.2012.0020010.3389/fonc.2012.00200 ↗
14. 10.1089/ars.2013.519510.1089/ars.2013.5195 ↗
15. 10.1016/j.ceca.2004.02.01110.1016/j.ceca.2004.02.011 ↗
16. 10.1021/bi012104810.1021/bi0121048 ↗
17. Olsen S · FASEB J · 2012 · 26 · 573
18. 10.1081/BIO-12000272510.1081/BIO-120002725 ↗
19. 10.1152/physrev.00011.200510.1152/physrev.00011.2005 ↗
20. 10.1111/j.1525-1594.2011.01296.x10.1111/j.1525-1594.2011.01296.x ↗
21. 10.1038/jcbfm.2008.15210.1038/jcbfm.2008.152 ↗
22. 10.1016/j.neuroscience.2007.02.06610.1016/j.neuroscience.2007.02.066 ↗
23. 10.1096/fj.12-21725710.1096/fj.12-217257 ↗
24. 10.1001/jama.282.19.185710.1001/jama.282.19.1857 ↗
25. 10.1016/j.yjmcc.2011.11.00510.1016/j.yjmcc.2011.11.005 ↗
26. 10.1529/biophysj.107.11431410.1529/biophysj.107.114314 ↗
27. 10.1097/MCO.0b013e32834136f210.1097/MCO.0b013e32834136f2 ↗
28. 10.1152/ajpheart.00307.200310.1152/ajpheart.00307.2003 ↗
29. 10.1042/BJ2004015610.1042/BJ20040156 ↗
30. 10.1111/trf.1264310.1111/trf.12643 ↗
31. 10.1042/BJ2006080910.1042/BJ20060809 ↗
32. 10.1046/j.1537-2995.2003.00341.x10.1046/j.1537-2995.2003.00341.x ↗
33. 10.1016/S0301-4622(97)00079-310.1016/S0301-4622(97)00079-3 ↗
34. 10.1053/j.jvca.2008.08.00610.1053/j.jvca.2008.08.006 ↗
35. 10.1097/01.CCM.0000172648.55309.1310.1097/01.CCM.0000172648.55309.13 ↗
36. 10.1097/TA.0b013e31815bd7b010.1097/TA.0b013e31815bd7b0 ↗
37. 10.1161/STROKEAHA.107.48650610.1161/STROKEAHA.107.486506 ↗